MAPK3 and neuroblastoma: Also, in this neuroblastoma model, the downregulation of PHLDA1 caused the increased levels of ERK1/2 in epidermal growth factor (EGF)-treated cells and non-treated cells as well as increased phosphorylation of ERK1/2 in EGF-stimulated cells.